FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Equine Vet J / Intralesional bone marrow and superior check desmotomy is su...
Equine veterinary journal2022; 54(6); 1047-1054; doi: 10.1111/evj.13553

Intralesional bone marrow and superior check desmotomy is superior to conservative treatment of equine superficial digital flexor tendonitis.

Abstract: Superficial digital flexor tendon (SDFT) injury is common in racehorses and a significant cause of lost training days and wastage in the industry. Objective: To compare the post-injury performance of Thoroughbred and Standardbred racehorses diagnosed with SDFT tendonitis treated with intralesional bone marrow and superior check desmotomy or managed conservatively and further to compare this performance with that of uninjured racehorses. Methods: Retrospective and case-controlled. Methods: Medical and race records of racehorses treated surgically or managed conservatively for SDFT tendonitis were collated. Signalment, lesion severity and treatment were identified and performance post-injury compared. Performance of the treatment groups was further assessed by comparison with uninjured racehorses matched for age, sex, number of starts pre-injury and randomly selected from the cases' last races. Results: The study population comprised 114 racehorses divided into surgical (39/114), conservative (38/114) and control groups (37/114). Horses that had surgery were more likely to return to racing than those managed conservatively (OR 4.7 95% CI [1.6-14.3], P = .006). Standardbreds were more likely to return to race compared with Thoroughbreds (OR 4.0 95% CI [1.2-13.3], P = .03). There was no statistically significant difference in the average number of placings, average number of wins and post-injury earnings between the surgically treated and conservatively managed groups (P = .9, P = .9 and P = .7, respectively). The average number of lifetime starts post-injury/post-selection between surgery, conservative and control groups were not statistically significantly different (P = .2). Surgically treated horses had a statistically significantly shorter time to start post-injury compared with the conservative group (P = .04). Conclusions: The retrospective nature of the study precludes an actual fit as a nonrandomised clinical trial and the nonrandomised nature of the allocation of the treatment groups is biased. Conclusions: Surgical intervention of superficial digital flexor tendonitis in racehorses suffering flexor tendon injury showed a higher likelihood of return to racing than conservative treatment.
© 2022 EVJ Ltd.
Get Full Text
Publication Date: 2022-01-14 PubMed ID: 35000213DOI: 10.1111/evj.13553Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Clinical Trial
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article is about a study proving that surgical treatment, specifically intralesional bone marrow and superior check desmotomy, is more effective for racehorses with superficial digital flexor tendonitis compared to conservative treatment.

Objective and Methodology

The study aimed to compare post-injury performance of Thoroughbred and Standardbred racehorses with superficial digital flexor tendonitis that was treated either with intralesional bone marrow and superior check desmotomy or managed conservatively. In addition, the performance of these horses was compared with that of uninjured racehorses.

The researchers gathered medical and race records of horses treated for this condition. They identified the characteristics of the horse, severity of the lesion and the treatment used, and then compared post-injury performance among them. Moreover, they studied the treatment groups’ performance against 37 uninjured racehorses that matched the age, sex, and number of pre-injury starts of the treatment groups. The selection of these uninjured horses was random from the cases’ last races.

Results

The results of this study are as follows:

  • The study included 114 racehorses: 39 treated surgically, 38 managed conservatively, and 37 uninjured racehorses serving as control group.
  • Horses that underwent surgery were more likely to return to racing compared to those managed conservatively.
  • When comparing horse breeds, Standardbreds had a higher likelihood of returning to the race post-injury than Thoroughbreds.
  • No statistically significant difference was found in the average number of placings, average number of wins, and earnings post-injury between the surgically treated and the conservatively managed groups.
  • Comparing the average number of lifetime starts post-injury or post-selection of all three groups did not reveal any statistically significant difference.
  • However, the time it took for surgically treated horses to start races post-injury was shorter than that for the conservatively managed group.

Conclusion

The retrospective nature of this study prevents it from fitting into a nonrandomized clinical trial, and the nonrandomized allocation of treatment groups could have caused bias. However, overall, the study concludes that surgical intervention in treating superficial digital flexor tendonitis in racehorses leads to a higher probability of the horses returning to races compared to conservative treatment.

Cite This Article

APA
Murphy DJ, Kö-Peternelj V, Aleri JW. (2022). Intralesional bone marrow and superior check desmotomy is superior to conservative treatment of equine superficial digital flexor tendonitis. Equine Vet J, 54(6), 1047-1054. https://doi.org/10.1111/evj.13553

Publication

Equine veterinary journal
ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 54
Issue: 6
Pages: 1047-1054

Researcher Affiliations

Murphy, David John
  • School of Veterinary Medicine, College of Science, Health, Engineering and Education, Murdoch University, Perth, Western Australia, Australia.
Kö-Peternelj, Victoria
  • Belvoir Equine Clinic, Belhus, Western Australia, Australia.
Aleri, Joshua Wafula
  • School of Veterinary Medicine, College of Science, Health, Engineering and Education, Murdoch University, Perth, Western Australia, Australia.

MeSH Terms

  • Animals
  • Bone Marrow
  • Conservative Treatment / adverse effects
  • Conservative Treatment / veterinary
  • Horse Diseases / epidemiology
  • Horses
  • Retrospective Studies
  • Tendinopathy / therapy
  • Tendinopathy / veterinary

Grant Funding

  • Murdoch University

References

This article includes 39 references
  1. Alzola R, Easter C, Riggs CM, Gardner DS, Freeman SL. Ultrasonographic-based predictive factors influencing successful return to racing after superficial digital flexor tendon injuries in flat racehorses: a retrospective cohort study in 469 Thoroughbred racehorses in Hong Kong. Equine Vet J 2018;50:602-8.
  2. Dowling BA, Dart AJ, Hodgson DR, Smith RK. Superficial digital flexor tendonitis in the horse. Equine Vet J 2000;32:369-78.
  3. Kasashima Y, Takahashi T, Smith RKW, Goodship AE, Kuwano A, Ueno T. Prevalence of superficial digital flexor tendonitis and suspensory desmitis in Japanese Thoroughbred flat racehorses in 1999. Equine Vet J 2004;36:346-50.
  4. Tamura N, Kodaira K, Yoshihara E, Mae N, Yamazaki Y, Mita H. A retrospective cohort study investigating risk factors for the failure of Thoroughbred racehorses to return to racing after superficial digital flexor tendon injury. Vet J 2018;235:42-6.
  5. Hill AE, Blea JA, Arthur RM, McIlwraith CW. Non-fatal injury occurrence in Southern California Thoroughbred racehorses 2009-2010. Vet J 2015;205:98-100.
  6. Sawdon H, Yovich J, Booth T. Superficial digital flexor tendonitis in racehorses: long term follow-up of conservatively managed cases. Aust Equine Vet 1996;14:21-5.
  7. Crevier-denoix N, Collobert C, Pourcelot P, Denoix JM, Sanaa M, Geiger D. Mechanical properties of pathological equine superficial digital flexor tendons. Equine Vet J 1997;23:23-6.
  8. Dahlgren LA, Mohammed HO, Nixon AJ. Temporal expression of growth factors and matrix molecules in healing tendon lesions. J Orthop Res 2005;23:84-92.
  9. McKibbin LS, Paraschak DM. A study of the effects of lasering on chronic bowed tendons at Wheatley Hall Farm Limited, Canada, January 1983. Lasers Surg Med 1983;3:55-9.
  10. Bosch G, Lin YL, van Schie HTM, van De Lest CHA, Barneveld A, van Weeren PR. Effect of extracorporeal shock wave therapy on biochemical composition and metabolic activity of tenocytes in normal tendinous structures in ponies. Equine Vet J 2007;39:226-31.
  11. Kummerle JM, Theiss F, Smith RKW. Diagnosis and management of tendon and ligament disorders. Equine surgery 2019; p. 1411-45.
  12. Witte TH, Yeager AE, Nixon AJ. Intralesional injection of insulin-like growth factor-I for treatment of superficial digital flexor tendonitis in Thoroughbred racehorses: 40 cases (2000-2004). J Am Vet Med Assoc 2011;239:992-7.
  13. Geburek F, Gaus M, van Schie HT, Rohn K, Stadler PM. Effect of intralesional platelet-rich plasma (PRP) treatment on clinical and ultrasonographic parameters in equine naturally occurring superficial digital flexor tendinopathies - a randomized prospective controlled clinical trial. BMC Vet Res 2016;12:191.
  14. Pacini S, Spinabella S, Trombi L, Fazzi R, Galimberti S, Dini F. Suspension of bone marrow-derived undifferentiated mesenchymal stromal cells for repair of superficial digital flexor tendon in race horses. Tissue Eng 2007;13:2949-55.
  15. Smith RK. Mesenchymal stem cell therapy for equine tendinopathy. Disabil Rehabil 2008;30:1752-8.
  16. Godwin EE, Young NJ, Dudhia J, Beamish IC, Smith RK. Implantation of bone marrow-derived mesenchymal stem cells demonstrates improved outcome in horses with overstrain injury of the superficial digital flexor tendon. Equine Vet J 2012;44:25-32.
  17. Herthel D. Enhanced suspensory ligament healing in 100 horses by stem cells and other bone marrow components. Proc Am Assoc Equine Practnrs 2001;47:319-21.
  18. Asheim A. Surgical treatment of tendon injuries in the horse. J Am Vet Med Assoc 1964;145:447-51.
  19. Stromberg B, Tufvesson G, Nilsson G. Effect of surgical splitting on vascular reactions in the superficial flexor tendon of the horse. J Am Vet Med Assoc 1974;164:57-60.
  20. Bramlage LR. Superior check ligament desmotomy as a treatment for superficial digital flexor tendonitis: initial report. Proc Am Assoc Equine Practnrs 1986;32:365.
  21. Hawkins JF, Ross MW. Transection of the accessory ligament of the superficial digital flexor muscle for the treatment of superficial digital flexor tendinitis in standardbreds: 40 cases (1988-1992). J Am Vet Med Assoc 1995;206:674-8.
  22. Hogan PM, Bramlage LR. Transection of the accessory ligament of the superficial digital flexor tendon for treatment of tendinitis: long term results in 61 Standardbred racehorses (1985-1992). Equine Vet J 1995;27:221-6.
  23. Hu AJ, Bramlage LR. Racing performance of Thoroughbreds with superficial digital flexor tendonitis treated with desmotomy of the accessory ligament of the superficial digital flexor tendon: 332 cases (1989-2003). J Am Vet Med Assoc 2014;244:1441-8.
  24. Smith RK, McIlwraith CW. Consensus on equine tendon disease: building on the 2007 Havemeyer symposium. Equine Vet J 2012;44:2-6.
  25. Southwood LL, Stashak TS, Kainer RA, Wrigley RH. Desmotomy of the accessory ligament of the superficial digital flexor tendon in the horse with use of a tenoscopic approach to the carpal sheath. Vet Surg 1999;28:99-105.
  26. Smith RK, Korda M, Blunn GW, Goodship AE. Isolation and implantation of autologous equine mesenchymal stem cells from bone marrow into the superficial digital flexor tendon as a potential novel treatment. Equine Vet J 2003;35:99-102.
  27. Sutter WW. Autologous cell-based therapy for tendon and ligament injuries. Clin Tech Equine Pract 2007;6:198-208.
  28. Fulton IC, MacLean AA, O'Rielly JL, Church S. Superior check ligament desmotomy for treatment of superficial digital flexor tendonitis in thoroughbred and standardbred horses. Aust Vet J 1994;71:233-5.
  29. Gibson KT, Burbidge HM, Pfeiffer DU. Superficial digital flexor tendonitis in thoroughbred race horses: outcome following non-surgical treatment and superior check desmotomy. Aust Vet J 1997;75:631-5.
  30. Russell JW, Russell TM, Vasey JR, Hall MS. Autologous bone marrow aspirate for treatment of superficial digital flexor tendonitis in 105 racehorses. Vet Rec 2016;179:69.
  31. Wylie CE, Newton JR. A systematic literature search to identify performance measure outcomes used in clinical studies of racehorses. Equine Vet J 2018;50:304-11.
  32. O'Meara B, Bladon B, Parkin TD, Fraser B, Lischer CJ. An investigation of the relationship between race performance and superficial digital flexor tendonitis in the Thoroughbred racehorse. Equine Vet J 2010;42:322-6.
  33. Dyson SJ. Medical management of superficial digital flexor tendonitis: a comparative study in 219 horses (1992-2000). Equine Vet J 2004;36:415-9.
  34. Yovich J, Sawdon H, Booth T, Robertson I. Correlation of ultrasonographic findings and long term outcome in racehorses with superficial digital flexor tendon injury. Aust Equine Vet 1995;13:89-92.
  35. Verkade ME, Back W, Birch HL. Equine digital tendons show breed-specific differences in their mechanical properties that may relate to athletic ability and predisposition to injury. Equine Vet J 2020;52:320-5.
  36. Bertuglia A, Bullone M, Rossotto F, Gasparini M. Epidemiology of musculoskeletal injuries in a population of harness Standardbred racehorses in training. BMC Vet Res 2014;10:11.
  37. Thorpe CT, Clegg PD, Birch HL. A review of tendon injury: why is the equine superficial digital flexor tendon most at risk?. Equine Vet J 2010;42:174-80.
  38. Docheva D, Muller SA, Majewski M, Evans CH. Biologics for tendon repair. Adv Drug Deliv Rev 2015;84:222-39.
  39. Schnabel LV, Fortier LA, Mcillwraith CW, Nobert K. Therapeutic use of stem cells in horses: which type, how and when?. Vet J 2013;197:570-7.

Citations

This article has been cited 0 times.
Subscribe to our newsletter
Join 99,357 horse owners like you who receive our email updates on horse health and nutrition.